MAP3K7 and Miyoshi myopathy: Hence, it is of interest to explore its role in therapeutic interventions.21 It was found in our luciferase reporter assay that there was a binding site between MAP3K7 and miR‐129, and an inverse correlation between MAP3K7 and miR‐129 in the serum samples of MM patients, which discloses the role of MAP3K7 as a direct target of miR‐129.